Skip to main content

Table 12 Risk factors for venous thromboembolism in cancer patients

From: Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study

Variable β coefficient SE P value
1 Cisplatin based chemotherapy 1.034 0.35 0.003
2 Age (years) 0.01 0.015 0.42
3 ECOG poor 0.79 0.44 0.07
4 Female 0.41 0.31 0.19
5 GCSF never 0   
   < 50% of the cycles 0.13 0.37  
   > 50% of the cycles 0.87 0.45  
  all 0.15 0.51 0.17
6 Stage early 0   
  locally advanced −0.42 0.63  
  metastatic −0.17 0.61 0.67
7 CVC present 0.74 0.31 0.01
8 Khorana Risk low 0   0.07
  intermediate −0.91 0.46  
  high −0.85 0.37